Truncation artifact on PET/CT: impact on measurements of activity concentration and assessment of a correction algorithm.

OBJECTIVE Discrepancy between fields of view (FOVs) in a PET/CT scanner causes a truncation artifact when imaging extends beyond the CT FOV. The purposes of this study were to evaluate the impact of this artifact on measurements of 18F-FDG activity concentrations and to assess a truncation correction algorithm. MATERIALS AND METHODS Two phantoms and five patients were used in this study. In the first phantom, three inserts (water, air, bone equivalent) were placed in a water-filled cylinder containing 18F-FDG. In the second phantom study, a chest phantom and a 2-L bottle fitted with a bone insert were used to simulate a patient's torso and arm. Both phantoms were imaged while positioned centrally (baseline) and at the edge of the CT FOV to induce truncation. PET images were reconstructed using attenuation maps from truncated and truncation-corrected CT images. Regions of interest (ROIs) drawn on the inserts, simulated arm, and background water of the baseline truncated and truncation-corrected PET images were compared. In addition, extremity malignancies of five patients truncated on CT images were reconstructed with and without correction and the maximum standard uptake values (SUVs) of the malignancies were compared. RESULTS Truncation artifact manifests as a rim of high activity concentration at the edge of the truncated CT image with an adjacent low-concentration region peripherally. The correction algorithm minimizes these effects. Phantom studies showed a maximum variation of -5.4% in the truncation-corrected background water image compared with the baseline image. Activity concentration in the water insert was 6.3% higher while that of air and bone inserts was similar to baseline. Extremity malignancies showed a consistent increase in the maximum SUV after truncation correction. CONCLUSION Truncation affects measurements of 18F-FDG activity concentrations in PET/CT. A truncation-correction algorithm corrects truncation artifacts with small residual error.

[1]  V. Bettinardi,et al.  Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[2]  R. Wahl,et al.  PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  L. Kostakoglu,et al.  18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  D W. Townsend,et al.  Combined PET/CT Imaging in Oncology. Impact on Patient Management. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.

[5]  G. V. von Schulthess,et al.  Why most PET of lung and head-and-neck cancer will be PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  P. Rigo,et al.  Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer , 1998, European Journal of Nuclear Medicine.

[7]  O. Mawlawi,et al.  Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[9]  Thomas Beyer,et al.  Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. , 2003, Radiology.

[10]  M. Boers,et al.  Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial , 2002, The Lancet.

[11]  M. Schwaiger,et al.  Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Yuji Nakamoto,et al.  Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  Thomas Beyer,et al.  Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  H. Groen,et al.  Preoperative staging of non-small-cell lung cancer with positron-emission tomography. , 2000, The New England journal of medicine.

[15]  K. Bae,et al.  Efficient correction for CT image artifacts caused by objects extending outside the scan field of view. , 2000, Medical physics.

[16]  J. Hsieh,et al.  A novel reconstruction algorithm to extend the CT scan field-of-view. , 2004, Medical physics.

[17]  H Zaidi,et al.  Optimisation of whole-body PET/CT scanning protocols , 2007, Biomedical imaging and intervention journal.

[18]  Haim Azhari,et al.  The reduction of artifacts due to metal hip implants in CT-attenuation corrected PET images from hybrid PET/CT scanners , 2007, Medical & Biological Engineering & Computing.

[19]  Habib Zaidi,et al.  Advances in Attenuation Correction Techniques in PET. , 2007, PET clinics.

[20]  Eriko Tsukamoto,et al.  PET/CT today: System and its impact on cancer diagnosis , 2006, Annals of nuclear medicine.

[21]  R. Cerfolio,et al.  Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma. , 2003, The Journal of thoracic and cardiovascular surgery.

[22]  Jeffrey A. Fessler,et al.  3D PET reconstruction with FORE and WLS-OS-EM , 2002, 2002 IEEE Nuclear Science Symposium Conference Record.

[23]  V. Rusch,et al.  Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. , 2003, The Journal of thoracic and cardiovascular surgery.

[24]  Paul Kinahan,et al.  Attenuation correction for a combined 3D PET/CT scanner. , 1998, Medical physics.